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Alopecia areata (AA) is a nonscarring and recurrent disease characterized by hair loss that may significantly affect
patient health-related quality of life (HRQoL). Given the lack of reliable and accurate reporting of HRQoL status in
patients with AA, we analyzed data from 532 AA patients from the National Alopecia Areata Registry whose
registry record included HRQoL assessments using three validated instruments: Skindex-16, brief version of the
Fear of Negative Evaluation Scale, and Dermatology Life Quality Index. The mean HRQoL scores were compared
with previously reported HRQoL levels from healthy controls and patients with other skin diseases. Two-step
cluster analysis of Skindex-16 scales divided patients into two groups: 481 (57%) with good HRQoL and 361 (43%)
with poor HRQoL. Multivariate logistic regression modeling revealed a set of risk factors for poor HRQoL: age
o50 years (odds ratio (OR) 3.99, 95% confidence interval (CI) 1.66–9.58), female gender (OR 2.74, 95% CI 1.73–4.34),
hair loss 25–99% (OR 2.47, 95% CI 1.12–5.45), family stress (OR 1.8, 95% CI 1.13–2.86), and job change (OR 2.01, 95%
CI 1.02–3.94). The current analysis provides an overview of the HRQoL status of AA patients and may guide patient
care in the future.
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Given the lack of reliable and accurate reporting of health-
related quality of life (HRQoL) status in patients with alopecia
areata (AA), we conducted a secondary analysis of data from
the National Alopecia Areata Registry. We analyzed data from
532 AA patients whose registry record included HRQoL
assessments using three validated instruments: Skindex-16,
brief version of the Fear of Negative Evaluation Scale (BFNE),
and Dermatology Life Quality Index (DLQI). The specific aims
of this analysis were to: (1) describe the HRQoL status of a
nationwide sample of patients with AA; (2) identify patients
with higher risk for poor HRQoL during the course of AA; and
(3) determine risk factors for poor HRQoL in AA patients.
To identify patients with poor HRQoL, we applied a two-
step cluster analysis to partition patients into groups with
distinct levels of Skindex-16 scores (good vs. poor).(IBM SPSS
Statistics, 2011) With the three subscale scores of Skindex-16
as variables, the clustering solution was obtained using log-
likelihood estimation, and the optimal number of groups
was defined as that with the lowest Bayesian Information
Criterion.(Blashfield, 1980) To differentiate and describe the
groups, we calculated Cohen d effect size to compare the
severity of individual Skindex-16 subscale scores between the
good and poor HRQoL groups. The magnitude of the effect
size was based on the value of d, with 0.2 considered a small
effect size, 0.5 considered a medium effect size, and 0.8
considered a large effect size (Cohen, 1962).
Compared with the good HRQoL group, the poor HRQoL
group had significantly higher mean scores on the three
Skindex-16 subscales. Characteristics associated with poor
HRQoL included age between 20–50 years, female sex, and
change in physical appearance (lightened skin color, partial
hair loss). Changes in social status (e.g., family stress, change
of job) were also risk factors for poor HRQoL in AA patients.
The AA registry data contained 532 AA patients with
complete quality-of-life, demographic, and clinical informa-
tion. Over half were440 years, 73% were females, and 79%
were non-Hispanic whites. Fifty-two percent of patients were
diagnosed as alopecia universalis and alopecia totalis and
46.6% had 100% hair loss. The mean BFNE score was
35.5±9.9, and the mean DLQI score was 6.8±4.8. The three
Skindex-16 scores were: symptom scale 18.8±24.2, emo-
tional scale 43.3±33.3, and function scale 30.2±30.8. Using
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data from published studies, we found that the Skindex-16
emotional subscale scores for AA were not significantly
different from scores of patients with viral warts (43 vs. 48,
Po0.33) but were significantly better than scores from patients
with eczematous dermatitis (43 vs. 52, Po0.001). No differ-
ences were found between the Skindex-16 functional subscale
scores for AA vs. warts (30 vs. 24 Po0.28 or AA vs. dermatitis
(30 vs. 24, Po0.19). Although no differences were found
between patients with AA and patients with warts on the
Skindex-16 symptom subscale (19 vs. 23, Po0.33), patients
with eczematous dermatitis has significantly worse symptom
scores (19 vs. 42, Po0.001).
Two-step clustering generated two groups: a good
HRQoL group (n¼241; 45.3%) and a poor HRQoL
group with significantly higher mean Skindex-16 scores
(n¼ 291; 54.7%). Effect sizes of differences between the good
and poor HRQoL groups for all three Skindex-16 subscale
scores were higher than 1, indicating a large magnitude of
effect.
Multivariate logistic regression modeling revealed a set of
risk factors for poor HRQoL: age between 20–50 years (odds
ratio (OR) 3.99, 95% confidence interval (CI) 1.66–9.58),
female sex (OR 2.74, 95% CI 1.73–4.34), lighter skin color
change (OR 5.16, 95%CI 1.53–17.37), hair loss 26–50% (OR
2.47, 95% CI 1.12–5.45), hair loss 76–99% (OR 3.06, 95%CI
1.48–6.33), family stress (OR 1.8, 95% CI 1.13–2.86), and job
change (OR 2.01, 95% CI 1.02–3.94).
Because our findings were derived from a population-based,
nationwide survey, they have implications for the clinical care
of AA patients, although no healthy controls were involved for
comparison. The finding that over half of AA patients in the
current study experienced poor HRQoL highlights the need for
routine health-care and symptom assessment and manage-
ment, especially psychological intervention may be useful in
selected patients for effective treatment.
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